Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested
in clinical symptoms that develop and persist in patients during and/or after discontinuing …

Androgenetic alopecia (AGA) is the most common nonscarring alopecia and is
characterised by distinct gradual patterned hair loss. AGA is mediated by genetic …

Introduction Oral minoxidil is an antihypertensive vasodilator known to stimulate hair growth.
The use of low-dose oral minoxidil for the treatment of male androgenetic alopecia (AGA) is …

Male androgenetic alopecia is a common condition and represents a major concern for
patients who experience this condition. While there are different treatments to stop hair loss …

Androgenetic alopecia (AGA) is a multifactorial disease that carries a significant
psychological burden with it. Dihydrotestosterone, the main pathogenic androgen in AGA, is …

Hair loss is a disorder in which the hair falls out from skin areas such as the scalp and the
body. Several studies suggest the use of herbal medicine to treat related disorders …

In general, nanometer-sized drug delivery systems have a natural tendency for
accommodation in the follicular cavities, which makes them advantageous in the treatment …

Lipids and lipid metabolism are critical factors in hair follicle (HF) biology, and cholesterol
has long been suspected of influencing hair growth. Altered cholesterol homeostasis is …

Simple Summary Dihydrotestosterone (DHT), the most potent androgen hormone, is an
important aetiologic factor of androgenetic alopecia (AGA), or hair loss. Steroid 5-alpha …

Androgenetic alopecia is the most common cause of hair loss [Br J Dermatol. 2011 Jan; 164
(1): 5–15]. Finasteride and minoxidil are the only approved treatments [J Am Acad Dermatol …